Lynparza and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Lynparza (olaparib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Magnesium, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Lynparza. It is created by eHealthMe based on reports of 12,309 people who have side effects when taking Lynparza from the FDA, and is updated regularly.

What is Lynparza?

Lynparza has active ingredients of olaparib. eHealthMe is studying from 12,322 Lynparza users. Check the latest studies of Lynparza.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,435 drugs and 2,773 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 15, 2026

12,309 people reported to have side effects when taking Lynparza.
Among them, 21 people (0.17%) have Sinusitis - acute.

Among these 21 people:

How long have people been on Lynparza when they have Sinusitis - acute? *

What is the gender of people who have Sinusitis - acute when taking Lynparza? *

female: 80 %
male: 20 %

What is the age of people who have Sinusitis - acute when taking Lynparza? *

What are other drugs people take besides Lynparza? *

What are other side effects people have besides Sinusitis - acute? *

Fatigue (feeling of tiredness): 9 people, 42.86%
Nausea (feeling of having an urge to vomit): 7 people, 33.33%
Thrombocytopenia (decrease of platelets in blood): 6 people, 28.57%
Red Blood Cell Count Decreased: 5 people, 23.81%
Neuropathy Peripheral (surface nerve damage): 5 people, 23.81%
Anaemia (lack of blood): 5 people, 23.81%
Indigestion: 5 people, 23.81%
Malignant Neoplasm Progression (cancer tumour came back): 5 people, 23.81%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 19.05%
Back Pain: 4 people, 19.05%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 12 people, 57.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
Blood Pressure Abnormal: 3 people, 14.29%
Prostate Cancer Metastatic: 2 people, 9.52%
Blood Glucose Abnormal: 2 people, 9.52%
Metastatic Uterine Cancer (spreadable cancer of uterus): 2 people, 9.52%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 2 people, 9.52%
Indigestion: 2 people, 9.52%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 4.76%
Blood Magnesium Decreased: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Lynparza and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lynparza:

Lynparza (12,322 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Lynparza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,435 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olaparib (the active ingredients of Lynparza) and Lynparza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.